The IBN SINA Pharmaceutical Industry Ltd is a Bangladesh-based pharmaceutical company. The Company is engaged in production, trading, and other related activities of Active Pharmaceutical Ingredients (API) and other related products. The Company offers its products under pharma and natural. Its products in a range of therapeutic class, such as Antibiotic, Anti-ulcerant, Antiasthmatic, Antihistamine, Cough Medicines, Antidiabetic, Antispasmodic, Antineuropathic, Cardiovascular drugs (CVS drugs), Central Nervous System (CNS drugs), Gastroprokinetic agent, NSAIDs (nonsteroidal anti-inflammatory drugs) and Laxative. In Antibiotics the Company is enriched in Penicillins with brands Sinamox, Sinaclox, Sinaflox, among others. In Anti-ulcerant portfolio having pioneer brands like Dexlan and Gavisol. Antiasthmatic drugs including Ventisal, Ventisal-L, Xofyl, Montex, among others. Antihistamine brands including Bilamin, Fexomin, Rupamin, Ebamin, Sinamin, Nosemin, Silora, among others.
More about the company